This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $33,570.26 and an ultimate completion date of December 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has a ceiling value of $16,471.93 and a completion date of April 24, 2024. It is a firm fixed-price contract, with no set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Actemra (tocilizumab) 162 mg/0.9 mL syringes. The contract is a firm fixed-price delivery order with a ceiling value of $5,755.68 and a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The delivery order is priced at a firm fixed price of $12,604.63 and has a completion date of March 5, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML syringes, a specialty medication. The delivery order has a firm fixed price ceiling value of $18,120.33 and is scheduled for completion by March 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is valued at $12,604.63 and has an ultimate completion date of February 4, 2025. The contract covers the provision of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The contract has a firm fixed price and a ceiling value of $11,827.51. It has an ultimate completion date of August 5, 2024. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,091.41 firm fixed price contract is for the supply of the specialty pharmaceutical product SKYRIZI 150 MG/ML PENML. The delivery order has a completion date of February 21, 2024 and was awarded on February 20, 2024. This delivery order is likely issued under a larger indefinite...